SFI
PYXS icon

Susquehanna Fundamental Investments’s Pyxis Oncology PYXS Stock Holding History

Susquehanna Fundamental Investments’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$189K Sell
57,025
-25,422
-31% -$107K ﹤0.01% 852
2024
Q1 		$351K Buy
+82,447
New +$347K 0.02% 524

Other funds holding PYXS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna Fundamental Investments's PYXS Position: Q2 2024 in Review

Susquehanna Fundamental Investments reduced its Pyxis Oncology (PYXS) stake by 31% in Q2 2024, selling an estimated $107K and leaving 57,025 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #852.

Susquehanna Fundamental Investments first reported a position in PYXS in Q1 2024 and has held it in 2 quarters since. The position peaked at $351K in Q1 2024. 80 funds tracked by Wall St. Rank hold PYXS as of Q2 2024.

  • Susquehanna Fundamental Investments held 57,025 shares of Pyxis Oncology worth $189K as of Q2 2024.
  • Susquehanna Fundamental Investments sold 25,422 Pyxis Oncology shares in Q2 2024, an estimated $107K.
  • Pyxis Oncology made up ﹤0.01% of Susquehanna Fundamental Investments's portfolio in Q2 2024, its #852 holding.
  • Susquehanna Fundamental Investments first reported a position in Pyxis Oncology in Q1 2024 and has held it in 2 quarters since.
  • Susquehanna Fundamental Investments's Pyxis Oncology position peaked at $351K in Q1 2024.
  • 80 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2024.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2024, filed 15 Aug 2024.